News

US FDA approves syringe version of Argenx's immune disorder drug
The U.S. Food and Drug Administration has approved a prefilled syringe version of Netherlands-based Argenx SE's blockbuster ...
FiercePharma22d
Argenx stays on a roll with Vyvgart, gaining FDA nod for at-home prefilled syringe
Already thriving with a successful launch of infused Vyvgart and its subcutaneous follow-on Vyvgart ... has signed off on argenx’s prefilled syringe (PFS) version of Vyvgart Hytrulo, which ...
GlobalData on MSN2mon
EMA approves Takeda’s Takhzyro pre-filled pen option for HAE
It marks an expansion in the company’s portfolio for subcutaneous administration methods. Takhzyro has secured approval for ...
Seeking Alpha23d
Halozyme Announces FDA Approval of argenx's VYVGART® Hytrulo Prefilled Syringe Co-Formulated with ENHANZE® for Self-Injection for Generalized Myasthenia Gravis and Chronic ...
VYVGART ® Hytrulo prefilled syringe for self-injection is approved as a 20-to-30-second subcutaneous injection administered by a patient, caregiver, or healthcare professional. Patients are able ...
Hosted on MSN22d
US FDA approves syringe version of Argenx's immune disorder drug
Argenx said the Vyvgart Hytrulo prefilled syringe will be available within the next two weeks and that it would have a comparable price to the subcutaneous vial. "The new version is going to make ...